Literature DB >> 27436717

Cardiovascular disease and diagnosis of amyotrophic lateral sclerosis: A population based study.

Marianthi-Anna Kioumourtzoglou1, Ryan M Seals2, Ole Gredal3, Murray A Mittleman2, Johnni Hansen4, Marc G Weisskopf1,2.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a rapidly fatal neurodegenerative disease of unknown etiology. We investigated the association between ALS diagnosis and prior cardiovascular disease (CVD), and CVD-specific, hospital admissions in the Danish population. We conducted a population based nested case-control study, including 3182 Danish residents diagnosed with ALS at age ≥20 years (1982-2009) and 100 randomly selected controls for each case, matched on age, gender and vital status. We estimated odds ratios (OR) associated with CVD, and CVD-specific hospital admissions, adjusting for socioeconomic and marital status, region of residence and past diabetes and obesity diagnoses. The estimated adjusted OR for any CVD admission at least three years prior to the date of ALS diagnosis was 1.15 (95% CI 1.04-1.27). Our results varied across cause-specific admissions; for atherosclerosis the OR was 1.36 (95% CI 1.02-1.80) and for ischemic heart disease 1.14 (95% CI 0.99-1.31), while we observed no association with hypertensive and cerebrovascular diseases. Adjusting for or stratifying by COPD status, a cigarette-smoking correlate, did not change our results. In conclusion, in our population based study we found evidence for a moderately elevated association with CVD that was stronger for specific conditions, such as atherosclerosis. Our findings may have important implications for ALS pathogenesis.

Entities:  

Keywords:  Amyotrophic lateral sclerosis (ALS); atherosclerosis; cardiovascular disease (CVD); ischemic heart disease

Mesh:

Year:  2016        PMID: 27436717      PMCID: PMC5178102          DOI: 10.1080/21678421.2016.1208247

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  26 in total

1.  Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study.

Authors:  Martin R Turner; Clare Wotton; Kevin Talbot; Michael J Goldacre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-11-09       Impact factor: 10.154

Review 2.  Energy metabolism in amyotrophic lateral sclerosis.

Authors:  Luc Dupuis; Pierre-François Pradat; Albert C Ludolph; Jean-Philippe Loeffler
Journal:  Lancet Neurol       Date:  2010-10-27       Impact factor: 44.182

Review 3.  Statins and amyotrophic lateral sclerosis--the level of evidence for an association.

Authors:  H Toft Sørensen; T L Lash
Journal:  J Intern Med       Date:  2009-12       Impact factor: 8.989

4.  Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study.

Authors:  Marianthi-Anna Kioumourtzoglou; Ran S Rotem; Ryan M Seals; Ole Gredal; Johnni Hansen; Marc G Weisskopf
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

5.  Comparison of diagnoses of amyotrophic lateral sclerosis by use of death certificates and hospital discharge data in the Danish population.

Authors:  Marianthi-Anna Kioumourtzoglou; Ryan M Seals; Liselotte Himmerslev; Ole Gredal; Johnni Hansen; Marc G Weisskopf
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-05-06       Impact factor: 4.092

Review 6.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

7.  Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis.

Authors:  N A Sutedja; Y T van der Schouw; K Fischer; E M Sizoo; M H B Huisman; J H Veldink; L H Van den Berg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-04-06       Impact factor: 10.154

Review 8.  Amyotrophic lateral sclerosis.

Authors:  J D Mitchell; G D Borasio
Journal:  Lancet       Date:  2007-06-16       Impact factor: 79.321

9.  Physical activity and amyotrophic lateral sclerosis: a European population-based case-control study.

Authors:  Elisabetta Pupillo; Paolo Messina; Giorgia Giussani; Giancarlo Logroscino; Stefano Zoccolella; Adriano Chiò; Andrea Calvo; Massimo Corbo; Christian Lunetta; Benoit Marin; Douglas Mitchell; Orla Hardiman; James Rooney; Zorica Stevic; Monica Bandettini di Poggio; Massimiliano Filosto; Maria Sofia Cotelli; Michele Perini; Nilo Riva; Lucio Tremolizzo; Eugenio Vitelli; Danira Damiani; Ettore Beghi
Journal:  Ann Neurol       Date:  2014-05-21       Impact factor: 10.422

Review 10.  The Danish National Patient Registry: a review of content, data quality, and research potential.

Authors:  Morten Schmidt; Sigrun Alba Johannesdottir Schmidt; Jakob Lynge Sandegaard; Vera Ehrenstein; Lars Pedersen; Henrik Toft Sørensen
Journal:  Clin Epidemiol       Date:  2015-11-17       Impact factor: 4.790

View more
  9 in total

1.  Amyotrophic Lateral Sclerosis Among Veterans Deployed in Support of Post-9/11 U.S. Conflicts.

Authors:  Hari Krishna Raju Sagiraju; Sasa Živković; Anne C VanCott; Huned Patwa; David Gimeno Ruiz de Porras; Megan E Amuan; Mary Jo V Pugh
Journal:  Mil Med       Date:  2020-03-02       Impact factor: 1.437

2.  Joint and interactive effects between health comorbidities and environmental exposures in predicting amyotrophic lateral sclerosis.

Authors:  Andrea Bellavia; Aisha S Dickerson; Ran S Rotem; Johnni Hansen; Ole Gredal; Marc G Weisskopf
Journal:  Int J Hyg Environ Health       Date:  2020-10-30       Impact factor: 5.840

3.  Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders.

Authors:  Estela Area-Gomez; H Mitsumoto; D Larrea; T Yun; Y Xu; J Hupf; F Zandkarimi; R B Chan
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

4.  Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis.

Authors:  Sara Bandres-Ciga; Alastair J Noyce; Gibran Hemani; Aude Nicolas; Andrea Calvo; Gabriele Mora; Pentti J Tienari; David J Stone; Mike A Nalls; Andrew B Singleton; Adriano Chiò; Bryan J Traynor
Journal:  Ann Neurol       Date:  2019-03-13       Impact factor: 10.422

5.  Candidate SNP Markers of Atherogenesis Significantly Shifting the Affinity of TATA-Binding Protein for Human Gene Promoters show stabilizing Natural Selection as a Sum of Neutral Drift Accelerating Atherogenesis and Directional Natural Selection Slowing It.

Authors:  Mikhail Ponomarenko; Dmitry Rasskazov; Irina Chadaeva; Ekaterina Sharypova; Irina Drachkova; Dmitry Oshchepkov; Petr Ponomarenko; Ludmila Savinkova; Evgeniya Oshchepkova; Maria Nazarenko; Nikolay Kolchanov
Journal:  Int J Mol Sci       Date:  2020-02-05       Impact factor: 5.923

6.  Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis.

Authors:  Alexander G Thompson; Kevin Talbot; Martin R Turner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-09-13       Impact factor: 10.154

7.  Key Disease Mechanisms Linked to Amyotrophic Lateral Sclerosis in Spinal Cord Motor Neurons.

Authors:  Virginie Bottero; Jose A Santiago; James P Quinn; Judith A Potashkin
Journal:  Front Mol Neurosci       Date:  2022-03-15       Impact factor: 5.639

8.  Pre-diagnostic plasma lipid levels and the risk of amyotrophic lateral sclerosis.

Authors:  Kjetil Bjornevik; Éilis J O'Reilly; Marianna Cortese; Jeremy D Furtado; Laurence N Kolonel; Loic Le Marchand; Marjorie L Mccullough; Sabrina Paganoni; Michael A Schwarzschild; Aladdin H Shadyab; Joann E Manson; Alberto Ascherio
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2020-09-28       Impact factor: 4.092

9.  ALS in Danish Registries: Heritability and links to psychiatric and cardiovascular disorders.

Authors:  Betina B Trabjerg; Fleur C Garton; Wouter van Rheenen; Fang Fang; Robert D Henderson; Preben Bo Mortensen; Esben Agerbo; Naomi R Wray
Journal:  Neurol Genet       Date:  2020-02-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.